Scottish Cannabidiol (CBD) and hemp seed oil product provider Voyager has announced its intention to list on the Aquis Stock Exchange Growth Market.
In February, the Perthshire-based business launched a crowdfunding campaign through Seedrs, raising £874,000.
Earlier this month, Voyager has raised a further £741,000 privately, including a commitment of £100,000 from Greencare Capital, the Aquis-listed investment company focused on medicinal cannabis and related areas.
Voyager was incorporated in November 2020 as a health and wellness business. The statement explained that its directors believe that a significant opportunity exists in the CBD market due to the forecast growth and ongoing regulatory changes.
The company has a growing range of CBD and hemp seed oil products – including oils, gummies, bath products and skincare products – available through its website and more than 20 third party sellers.
Chief executive Nick Tulloch said: “We believe this is a sector with significant growth potential and our focus has been on building our product range alongside a robust approach to assurance and compliance as strong foundations to build the brand and the business.
“At the time of our crowdfunding campaign in February 2021, we were clear with investors that our aspirations were to take Voyager onto the public markets when the time was right.
“The progress made by the business, coupled with strong investor backing, has enabled us to realise these plans far more rapidly than we originally envisaged.
“We believe that Aquis provides an ideal platform for Voyager to continue to build its profile and provide our investors with liquidity whilst maintaining the company’s EIS-qualifying status.”
Aquis is a UK-based primary and secondary market for equity and debt securities, which calls itself the home of growth companies.
Admission is expected to occur during the second quarter.
Don’t miss the latest headlines with our twice-daily newsletter – sign up here for free.